All the news

Long-term treatment with tenofovir (Viread) lowered the risk of developing hepatocellular carcinoma among people with chronic hepatitis B, with a notable divergence from expected rates after about  five years, according to a ...

A study involving people co-infected with HIV and hepatitis B virus (HBV) shows that antiretroviral therapy that combines tenofovir with FTC or 3TC has the best chance of suppressing HBV replication to undetectable ...

Intensifying entecavir (Baraclude) treatment for hepatitis B by adding pegylated interferon lowers HBV viral load and increases the likelihood of hepatitis B "e" antigen (HBeAg) loss, according to a presentation at The ...

Treatment of chronic hepatitis B with nucleoside analogues including lamivudine (Epivir) and entecavir (Baraclude) can reduce the risk of developing hepatocellular carcinoma, including cancer recurrence after successful resection surgery, according to data presented ...

Tenofovir (Viread) continues to be safe and effective for treating chronic hepatitis B through eight years of follow-up, researchers reported at The Liver Meeting 2012, the 63rd Annual Meeting of the American Association ...

People with HIV and hepatitis B virus (HBV) co-infection, who substituted tenofovir (Viread) for zidovudine (Retrovir) or abacavir (Ziagen) in their antiretroviral regimen, saw a reduction in hepatitis B viral load despite HBV ...

Liver-related outcomes are poorer in HIV-positive patients who are co-infected with hepatitis B virus genotype B compared to co-infected patients with hepatitis B genotype C, Taiwanese investigators report in the online edition of ...

The new edition of the European AIDS Clinical Society (EACS) treatment guidelines for people with HIV was published last week at the 13th European AIDS Conference in Belgrade, Serbia. ...

The inclusion of lamivudine (3TC) in antiretroviral therapy had few additional benefits for South African HIV-positive patients co-infected with hepatitis B, South African investigators report in the online edition of AIDS. Hepatitis B virus (HBV) ...

A combination of entecavir with Truvada is an effective and safe option for HIV/hepatitis B-co-infected patients whose current therapy is not suppressing hepatitis B viral load, investigators from the north of England ...